Vitrectomy decreases the progression of age-related macular degeneration (AMD), according to a new research study. There is no published evidence that a vitrectomy hastens the progression of AMD. Intraocular surgery is known however to incite significant inflammation and breakdown of the blood–ocular barrier, which may last from weeks to...

Some patients with geographic atrophy benefit for at least 3 years from an autologous graft of choroid and retinal pigment epithelium (RPE), according to a new research study. Geographic atrophy accounts for severe vision loss and blindness in about 40% of the patients with age-related macular degeneration (AMD). Therapeutic approaches are...

The outcome following transplantation of en bloc sheets of retinal pigment epithelium (RPE)-choroidal tissue and suspensions of RPE cells are similar, according to a new study. Prior to the advent of anti-VEGF drugs, such as Avastin and Lucentis, there was no effective treatment for subfoveal choroidal neovascular membranes. This prompted some...

Good visual outcomes 3 years following macuar translocation surgery for neovascular age-related macular degeneration (AMD) are reported by a new study. Results for surgical therapy of neovascular AMD have been generally disappointing. The MARAN (Macular Relocation in Age-related Neovascular disease) randomized, prospective, controlled clinical...

A combination of an anterior chamber IOL and posterior chamber IOL that functions like a Galilean telescope offers reasonable visual recovery for patients with sight-threatening age-related macular degeneration, according to a speaker. "The IOL-Vip system (LenSpecial) seems to be a promising new device for visual rehabilitation of patients...

Autologous translocation of retinal pigment epithelium (RPE) and choroid is not effective for the treatment of neovascular age-related macular degeneration (AMD) after an average follow-up of 11 months, according to a new study. Prior to the advent of anti-VEGF drugs, such as Avastin and Lucentis, there was no effective treatment for large...

A new study finds that pars plana vitrectomy (ppV) with subretinal coapplication of recombinant tissue plasminogen activator (TPA) and Avastin (bevacizumab), and fluid–gas exchange improved visual acuity in most patients with neovascular age-related macular degeneration (AMD) with submacular haemorrhage (SMH). Eyes with large subretinal...

A new study finds that cataract surgery is likely to benefit pateints with all stages of age-related macular degeneration (AMD), from mild to advanced. Cataract surgery is currently one of the most commonly performed surgeries in the United States. Cataract and age-related macular degeneration (AMD) often present concurrently in older persons....

Cataract surgery does not accelerate the progression of age-related macular degeneration (AMD), according to a new study. Cataract and AMD are strongly age-related; many individuals with cataract also have AMD. There has been a long-standing controversy among clinicians as to whether cataract surgery is contraindicated in eyes with...

A retrospective study of the visual and refractive outcome of visually impaired myopic adults treated with refractive surgery (photorefractive keratectomy [PRK] or laser-assisted in situ keratomileusis [LASIK]) finds that refractive surgery improved the best spectacle-corrected visual acuity in visually impaired patients. The researchers...